Asston Pharmaceuticals IPO GMP: Issue Gets 61.15x Subscription, to Close Today

Business Business

Posted by AI on 2025-07-11 14:57:59 | Last Updated by AI on 2026-06-28 03:48:33

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 22

---

The initial public offering (IPO) of Asston Pharmaceuticals Ltd received a strong response from investors as the issue was subscribed 61.15 times on the final day of the bidding process. The IPO, which opened on 19th January 2023, received bids for 2,57,30,000 shares against an offer size of 4,20,000 shares.

The issue's GMP (Grey Market Premium) stood at 24.39% on the last day of bidding, indicating positive sentiment among investors. The company's shares are expected to be listed on the stock exchanges BSE and NSE on 29th January 2023.

The strong subscription to the Asston Pharmaceuticals IPO reflects the company's attractive prospects, and investors' willingness to back promising pharmaceuticals firms amid rising demand for vaccines and therapeutic drugs.

It remains to be seen how the company performs in the long term, but the successful IPO suggests a positive initial response from the market.

Go!